Strategic innovation management of change in the pharmaceutical industry

International Journal of Technology Management

Volumn 25, Issue 3-4, 2003, Pages 314-333

  Halemane, Murthy D ^a   Van Dongen, Boudewijn ^b  

^a ERASMUS UNIVERSITY   (Netherlands)

^b 6 Brunel House   (United Kingdom)

Author keywords

Capabilities; Innovation strategy; Intellectual property rights; Pharmaceutical industry

Indexed keywords

COMPETITION; INTELLECTUAL PROPERTY; STRATEGIC PLANNING;

INNOVATION STRATEGY;

DRUG PRODUCTS PLANTS;

EID: 0037282317     PISSN: 02675730     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJTM.2003.003103     Document Type: Article

References (30)

1. Ballance, R., Pogány, J. and Forstner, H. (1992) The World's Pharmaceutical Industries, Edward Elgar Publishing Ltd, Aldershot.
2. Scherer, F.M. (1996) Industry, Structure, Strategy, and Public Policy, Harper Collins College Publishers, New York.
3. Tarabusi, C.C. and Vickery, G. (1998) 'Globalization in the pharmaceutical industry, Part II', International Journal of Health Services, Vol. 28, No. 2, pp.281-303.
4. Thomas, G.L. (1988) 'Multifirm strategies in the US pharmaceutical industry', in D.C. Mowery (Ed.) International Collaborative Ventures in US Manufacturing, Ballinger Publishing Company, Cambridge, Mass.
5. MacFarlane, F.G. (1997) 'Worldwide pharmaceutical R&D expenditure: can the growth continue?', International Journal of Pharmaceutical Medicine, Vol. 11, pp. 193-199.
6. Tarabusi, C.C. and Vickery, G. (1998) 'Globalization in the pharmaceutical industry, Part I', Intetrnational Journal of Heath Services, Vol. 28. No. 1, pp.67-105.
7. Pisano, G.P. (1991) 'The governance of innovation: vertical integration and collaboration arrangements in the biotechnology industry', Research Policy, Vol. 20, pp.237-249.
8. Barley, S.R., Freeman, J. and Hybels, R.C. (1992) 'Strategic alliances in commercial biotechnology', in N. Nohria and R.G. Eccles (Eds.) Networks and Organizations: Structure, Form, and Action, Harvard Business School, Boston.
9. Windhover Information Inc (1993) Pharmaceutical Strategic Alliances January 1992-June 1993, 4th Edition. Windhover Information, Inc., Norwalk, CT.
10. Twiss, B. (1992) Managing Technological Innovation, 4th Edition, Pitman Publishing, London.
11. De Wolf, P. (1997) European Harmonization in the Pharmaceutical Industry: Mission in Completion?, Erasmus University: Rotterdam.
12. Milmo, S. (1997) 'Fortunes change in Western Europe', Chemical Market Reporter, Vol. 251, No. 22, pp.10-12.
13. Henderson, R. and Mitchell, W. (1997) 'The interactions of organizational and competitive influences on strategy and performance', Strategic Management Journal, Summer Special Issue, Vol. 18, pp.5-14.
14. Van Dongen, B. (1997) Towards Strategic Innovation Management, Erasmus University Rotterdam, Rotterdam. The full report can be ordered from B. van Dongen, at dongennl@hotmail.com
15. Madan, A.K. (1994) Emerging Pharmaceutical Markets & Export Promotion Strategy, Indian Institute of Foreign Trade, New Delhi.
16. Berry, M.M.J. and Taggart, J.H. (1994) 'Managing technology and innovation: a review', R&D Management, Vol. 24, No. 4, pp.341-353.
17. Porter, M. (1980) Competitive Strategy, The Free Press, New York.
18. Rumelt, R. (1994) 'The evaluation of business strategy', in B. De Wit and R. Meyer (Eds.) Strategy: Process, Content, Context, West Publishing Company, St. Paul, pp.186-192.
19. Schülin, P. (1995) Strategisches Innovationsmanagement, Rosch-Buch, Hallstadt, p.374.
20. Cool, K.O. and Schendel, D. (1987) 'Strategic group formation and performance: the case of the US pharmaceutical industry, 1963-1982', Management Science, Vol. 33, No. 9, pp.1102-1124.
21. Porter, M.E. (1991) 'Towards a dynamic theory of strategy', Strategic Management Journal, Vol. 12, pp.95-117.
22. McGahan, A.M. and Porter, M.E. (1997) 'How much does industry matter, really?', Strategic Management Journal, Summer Special Issue, Vol. 18, pp. 15-30.
23. OECD (1985) The Pharmaceutical Industry, OECD, Paris.
24. Schütz, S. and Eichin, K-H. (1989) 'Internationale Perspektiven der Pharmaindustrie', in H. Simon, K. Hilleke-Daniel, and E. Kucher (Eds.), pp. 186-226.
25. De Wolf, P. (1994) 'The pharmaceutical industry', in F. Sachwald (Ed.) European Integration and Competitiveness, Edward Elgar, Aldershot, pp.277-317.
26. Taggart, J. (1993) The World Pharmaceutical Industry, Routledge, London.
27. Bower, J.D. (1993) 'New product development in the pharmaceutical industry: pooling network recources', Journal of Product Innovation Management, Vol. 10, pp. 367-375.
28. McCutchen, W.W.J. and Swamidass, P.M. (1998) 'Explaining the differences in domestic and cross-boundary strategic alliances in the pharmaceutical/biotech industry', International Journal of Technology Management, Vol. 15, pp.490-506.
29. Bogner, W.C. (1996) DRUGS TO MARKET Creating Value and Advantage in the Pharmaceutical Industry, Elsevier Science Ltd., Oxford.
30. ORG (1995) Operations Research Group Data, December.